WEST PHARMACEUTICAL SERVICES INC
WST$19.39B
Large CapNASDAQBiotechnology🇺🇸North America10.6K employees
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
May 15, 2026
16dMarket Overview
Stock performance and key metrics
WST News
Catalyst Timeline
1 upcoming, 2 past
Drug Pipeline
Morphine Sulfate
Pain, Postoperative
Phenobarbital
Epilepsy
Imetelstat sodium
Myelodysplastic Syndromes
Fish Oil
Intensive Care Unit
RVU120 (SEL120)
Low Risk Myelodysplastic Syndromes
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Morphine Sulfate | Phase 3 | Pain, Postoperative | - | - |
Phenobarbital | Phase 3 | Epilepsy | - | - |
Imetelstat sodium | Phase 2 | Myelodysplastic Syndromes | - | - |
Fish Oil | Phase 2 | Intensive Care Unit | - | - |
RVU120 (SEL120) | Phase 2 | Low Risk Myelodysplastic Syndromes | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply